Verley, a French biotechnology company, has received a “No Questions Letter” from the US Food and Drug Administration (FDA) for two of its dairy proteins produced using precision fermentation. This approval marks the first time the FDA has granted such clearance for dairy ingredients produced via this technology. The proteins, FermWhey Native and FermWhey MicroStab, are whey proteins made without the need for animal farming, providing a sustainable alternative to traditional dairy.

CEO Stéphane Mac Millan highlighted the company’s rapid progress since its establishment just three years ago, emphasizing the growing potential of precision fermentation. Verley plans to introduce its dairy proteins to the US market in 2026 and is also pursuing regulatory approval in other markets. This development positions Verley as a leader in providing sustainable protein alternatives to food and beverage manufacturers worldwide, with the company's focus on expanding globally in the near future.